105 related articles for article (PubMed ID: 27059097)
1. Mammalian target of rapamycin (mTOR) complex 2 regulates filamin A-dependent focal adhesion dynamics and cell migration.
Sato T; Ishii J; Ota Y; Sasaki E; Shibagaki Y; Hattori S
Genes Cells; 2016 Jun; 21(6):579-93. PubMed ID: 27059097
[TBL] [Abstract][Full Text] [Related]
2. Significance of filamin A in mTORC2 function in glioblastoma.
Chantaravisoot N; Wongkongkathep P; Loo JA; Mischel PS; Tamanoi F
Mol Cancer; 2015 Jul; 14():127. PubMed ID: 26134617
[TBL] [Abstract][Full Text] [Related]
3. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
4. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2.
Luo Y; Liu L; Wu Y; Singh K; Su B; Zhang N; Liu X; Shen Y; Huang S
Oncotarget; 2015 Feb; 6(6):4286-98. PubMed ID: 25738366
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
7. Dramatic suppression of colorectal cancer cell growth by the dual mTORC1 and mTORC2 inhibitor AZD-2014.
Huo HZ; Zhou ZY; Wang B; Qin J; Liu WY; Gu Y
Biochem Biophys Res Commun; 2014 Jan; 443(2):406-12. PubMed ID: 24309100
[TBL] [Abstract][Full Text] [Related]
8. 17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodeling.
Kusch A; Schmidt M; Gürgen D; Postpieszala D; Catar R; Hegner B; Davidson MM; Mahmoodzadeh S; Dragun D
PLoS One; 2015; 10(4):e0123385. PubMed ID: 25880554
[TBL] [Abstract][Full Text] [Related]
9. Mdm20 Modulates Actin Remodeling through the mTORC2 Pathway via Its Effect on Rictor Expression.
Yasuda K; Takahashi M; Mori N
PLoS One; 2015; 10(11):e0142943. PubMed ID: 26600389
[TBL] [Abstract][Full Text] [Related]
10. IKK interacts with rictor and regulates mTORC2.
Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
[TBL] [Abstract][Full Text] [Related]
12. PRICKLE1 Contributes to Cancer Cell Dissemination through Its Interaction with mTORC2.
Daulat AM; Bertucci F; Audebert S; Sergé A; Finetti P; Josselin E; Castellano R; Birnbaum D; Angers S; Borg JP
Dev Cell; 2016 May; 37(4):311-325. PubMed ID: 27184734
[TBL] [Abstract][Full Text] [Related]
13. Steady-state kinetic and inhibition studies of the mammalian target of rapamycin (mTOR) kinase domain and mTOR complexes.
Tao Z; Barker J; Shi SD; Gehring M; Sun S
Biochemistry; 2010 Oct; 49(39):8488-98. PubMed ID: 20804212
[TBL] [Abstract][Full Text] [Related]
14. Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.
Sun J; Liu Y; Moreno S; Baudry M; Bi X
J Neurosci; 2015 Mar; 35(11):4706-18. PubMed ID: 25788687
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
[TBL] [Abstract][Full Text] [Related]
16. mTORC1- and mTORC2-interacting proteins keep their multifunctional partners focused.
Bracho-Valdés I; Moreno-Alvarez P; Valencia-Martínez I; Robles-Molina E; Chávez-Vargas L; Vázquez-Prado J
IUBMB Life; 2011 Oct; 63(10):896-914. PubMed ID: 21905202
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.
Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH
Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748
[TBL] [Abstract][Full Text] [Related]
18. Activation of mTORC2 by association with the ribosome.
Zinzalla V; Stracka D; Oppliger W; Hall MN
Cell; 2011 Mar; 144(5):757-68. PubMed ID: 21376236
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 and mTORC2 have largely distinct functions in Purkinje cells.
Angliker N; Burri M; Zaichuk M; Fritschy JM; Rüegg MA
Eur J Neurosci; 2015 Oct; 42(8):2595-612. PubMed ID: 26296489
[TBL] [Abstract][Full Text] [Related]
20. Filamin-a increases the stability and plasma membrane expression of polycystin-2.
Wang Q; Zheng W; Wang Z; Yang J; Hussein S; Tang J; Chen XZ
PLoS One; 2015; 10(4):e0123018. PubMed ID: 25861040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
